ARCHIVES

ACS Challenged To Clarify Position On FDA Reform

This article is from The Cancer Letter archive.

Vol. 22 No. 09 | March 1, 1996

Download PDF Visit The Full Archive

Related Articles

Zytiga Plus Prednisone Shows Improvement in PFS and OS Over Prednisone Alone

June 29, 2012

NTP Board Oks Seven Compounds For Tests

April 22, 1983

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976

BRCA Carriers Live Longer Than Those With Normal Gene

January 25, 2008

$3.3 Million For Retinoid Contract Awarded

October 14, 1977

NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment

May 4, 2012